Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study.

Hareth NahiSaad Z UsmaniMaria-Victoria Mateos-MantecaNiels W C J van de DonkAlbert OriolTorben PlesnerNibedita BandyopadhyayPeter HellemansBrenda TrompIvo NnaneDonna ZemlickisAjai ChariPhilippe Moreau

Published in: Leukemia & lymphoma (2023)

Keyphrases

multiple myeloma
open label
clinical trial
acute lymphoblastic leukemia
acute myeloid leukemia
squamous cell carcinoma
diffuse large b cell lymphoma
phase ii
locally advanced